Options Medical Weight Loss review
Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at…
Est. first month
From $199/mo (compounded)
- Semaglutide
- From $199/mo (compounded)
- Tirzepatide
- From $399/mo (compounded)
- Coverage
- Coverage not published
- Brand-name
- Yes
The Value Score card
Options Medical Weight Loss scored on our six published factors. See the methodology.
Why it's a deal
- LegitScript certified with clear, upfront program pricing
- Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
- Structured metabolic-health program with provider support and accountability
- HSA/FSA eligible with flexible payment options
Read the fine print
- Doesn't clearly publish which states its telehealth covers
- Tirzepatide tiers climb to $339-$399/month
- More program structure (and cost) than medication-only sellers
- Compounded GLP-1 only online — no brand-name options noted
The bottom line
Best for: People wanting a structured medical weight-loss program with compounded GLP-1 and provider accountability. Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at…
Ranked #248 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.
Compare with other deals
The programs scoring closest to Options Medical Weight Loss, out of 394 others we track.
Shopping Options Medical Weight Loss against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Options Medical Weight Loss, and every program that undercuts or outscores it is ranked on the Options Medical Weight Loss alternatives board.
- From $199/mo (compounded)Nucore Health— Nucore Health is a physician-owned, LegitScript-certified telehealth platform serving all 50 states, focused on GLP-1 and longevity care: compounded semaglutide and tirzepatide (including a microdose…70/100
- From $190/mo (starting dose, plus a separate fee, compounded)Obu Health— Obu Health is a Las Vegas-based multi-product telehealth platform offering compounded semaglutide from $190/month and compounded tirzepatide from $239/month, plus NAD+ and sermorelin add-ons.70/100
- From $179/mo (starting dose, compounded)OnlyRx— OnlyRx is a cash-pay GLP-1 telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral disintegrating tablet (ODT) forms — an uncommon needle-free option.70/100
- $159/moUnique Physique— Unique Physique is a hybrid in-office and telehealth weight-loss clinic in Baton Rouge, Louisiana, with medical oversight from Reena John, DO.70/100
- From $179/mo (starting dose, compounded)VyrarX— VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.70/100
- $199/moSynergy Rx— A brand-name lane and unlimited clinical contact, at prices you cannot see until you are inside.69/100
More programs we track (24)
- #1 CoreAge Rx93
- #2 Ondra Health92
- #4 Vitara RX91
- #5 Gimme Care91
- #7 Alan Meds90
- #3 Trimi Health89
- #10 Precision Telemed89
- #11 bmiMD89
- #12 Care Clinics89
- #6 Oak88
- #16 Live Vital88
- #17 AmberHealth88
- #18 Fresh Day Meds88
- #8 Sesame Care87
- #9 Strut Health87
- #22 EverSlim87
- #23 NewSelf87
- #24 Vaylen87
- #25 Mint Med87
- #13 HealthRX86
- #14 RxSpan MD86
- #15 Sprout Health86
- #28 Bionomy Health86
- #29 BetterMe Rx86
364 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page were read from Options Medical Weight Loss's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Options Medical Weight Loss's site. Not medical advice; see our disclosure.